The effect of erythropoietin on blood parameters in thalassemia intermedia patients
نویسندگان
1 Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran
5 Shahid Sadoughi Uni
6 Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
7 Instructor of Nursing Education, Research Center for Nursing and Midwifery Care, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
doi
10.18502/ijpho.v12i4.10914چکیده
Background: β-thalassemia is the most common hereditary disease in Iran, and more than 2 million carriers of β-thalassemia live in Iran. On the other hand, our country is located in the thalassemia belt, and no comprehensive study has been conducted regarding the effect of erythropoietin on blood parameters in thalassemia intermedia ...